Based on these data, we propose that CXCL12-induced CXCR4 internalization can be used as a key parameter for the assessment of CXCR4 variant pathogenicity in vitro and as a potential disease biomarker for WHIM syndrome diagnosis. This evidence concerns the gene CXCR4 and WHIM syndrome.